13-36438154-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The ENST00000255465.8(CCNA1):ā€‹c.500A>Gā€‹(p.Tyr167Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 6.8e-7 ( 0 hom. )

Consequence

CCNA1
ENST00000255465.8 missense

Scores

11
5
3

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.30
Variant links:
Genes affected
CCNA1 (HGNC:1577): (cyclin A1) The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. The cyclin encoded by this gene was shown to be expressed in testis and brain, as well as in several leukemic cell lines, and is thought to primarily function in the control of the germline meiotic cell cycle. This cyclin binds both CDK2 and CDC2 kinases, which give two distinct kinase activities, one appearing in S phase, the other in G2, and thus regulate separate functions in cell cycle. This cyclin was found to bind to important cell cycle regulators, such as Rb family proteins, transcription factor E2F-1, and the p21 family proteins. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.938

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CCNA1NM_001111045.4 linkuse as main transcriptc.500A>G p.Tyr167Cys missense_variant 4/9 NP_001104515.2 P78396-3A0A140VJG0
CCNA1NM_001111046.2 linkuse as main transcriptc.500A>G p.Tyr167Cys missense_variant 4/9 NP_001104516.1 P78396-3
CCNA1NM_001111047.2 linkuse as main transcriptc.500A>G p.Tyr167Cys missense_variant 4/9 NP_001104517.1 P78396-3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CCNA1ENST00000255465.8 linkuse as main transcriptc.500A>G p.Tyr167Cys missense_variant 4/91 ENSP00000255465.5 P78396-1
CCNA1ENST00000625767.2 linkuse as main transcriptc.500A>G p.Tyr167Cys missense_variant 4/91 ENSP00000486017.2 P78396-2
CCNA1ENST00000440264.5 linkuse as main transcriptc.500A>G p.Tyr167Cys missense_variant 4/92 ENSP00000400666.1 P78396-3
CCNA1ENST00000630422.2 linkuse as main transcriptc.500A>G p.Tyr167Cys missense_variant 4/92 ENSP00000486482.1 P78396-3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461422
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
727022
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 21, 2023The c.632A>G (p.Y211C) alteration is located in exon 4 (coding exon 4) of the CCNA1 gene. This alteration results from a A to G substitution at nucleotide position 632, causing the tyrosine (Y) at amino acid position 211 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.86
BayesDel_addAF
Pathogenic
0.27
D
BayesDel_noAF
Pathogenic
0.15
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.67
.;.;D;.
Eigen
Pathogenic
0.98
Eigen_PC
Pathogenic
0.90
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
.;D;D;D
M_CAP
Benign
0.053
D
MetaRNN
Pathogenic
0.94
D;D;D;D
MetaSVM
Benign
-0.30
T
MutationAssessor
Uncertain
2.6
.;.;M;.
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Uncertain
0.73
T
PROVEAN
Pathogenic
-8.4
.;D;D;.
REVEL
Pathogenic
0.80
Sift
Pathogenic
0.0
.;D;D;.
Sift4G
Pathogenic
0.0
D;D;D;D
Polyphen
1.0, 1.0
.;.;D;D
Vest4
0.95
MutPred
0.76
.;.;Gain of helix (P = 0.0696);.;
MVP
0.74
MPC
1.4
ClinPred
1.0
D
GERP RS
5.9
Varity_R
0.87
gMVP
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr13-37012291; API